Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Using the Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy: A Randomized Controlled Trial (The Patch BRIDGE Trial)

NCT05790252 is registered in ClinicalTrials.gov with Washington University School of Medicine as lead sponsor.

NCT NCT05790252
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05790252 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Using the Transdermal Patch for BupRenorphine Induction DurinG PrEgnancy: A Randomized Controlled Trial (The Patch BRIDGE Trial)
Lead sponsor
Washington University School of Medicine
Phase
Phase 3
Overall status
Completed
Start date
November 27, 2023
Completion date
August 31, 2026
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

buprenorphine withdrawal, opioid use disorder, pregnancy complications, pregnancy related, pregnancy, high risk